PRS18 - Cost-Effectiveness Analysis of Omalizumab Compared With Standard of Care For Severe Allergic Asthma Based On Real World Evidence in Japan

Muthukumar, M ; Kozawa, M ; Alvares, L ; Milligan, K ; Igarashi, A

Value in health, 2018-09, Vol.21, p.S104-S105 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível